Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT03182686

Public ClinicalTrials.gov record NCT03182686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Study to Confirm the Efficacy of an Intra-Articular Injection of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized study to confirm the efficacy of an intra-articular injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee.

Study identification

NCT ID
NCT03182686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ampio Pharmaceuticals. Inc.
Industry
Enrollment
168 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2017 (Actual)
Primary completion
Dec 7, 2017 (Actual)
Completion
Dec 7, 2017 (Actual)
Last update posted
Aug 9, 2022

2017

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Central Research Associates, Inc. Birmingham Alabama 35205 —
CORE Orthopaedic Medical Center Encinitas California 92024 —
St. Joseph Heritage Fullerton California 92835 —
Artemis Institute for Clinical Research San Diego California 92103 —
Westlake Medical Research Thousand Oaks California 91360 —
Drug Studies America Marietta Georgia 30060 —
Healthcare Research Netword Blue Island Illinois 60406 —
Heartland Research Associates Wichita Kansas 67207 —
Arthritis Treatment Center Frederick Maryland 21702 —
Healthcare Network Research Hazelwood Missouri 63042 —
Coastal Carolina Center at Lowcountry Orthopaedics North Charleston South Carolina 29406 —
Tekton Research Austin Texas 78745 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03182686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2022 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03182686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →